Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Journal of Labelled Compounds & Radiopharmaceuticals|May 13, 2016
[(14) C]-AZD1152 drug substance manufacture: challenges of an IV-infusion dosed human mass balance study in patientsNick Bushby, Julie Bergin, John Harding
Biomaterials|January 9, 2010
A Streptococcus pyogenes derived collagen-like protein as a non-cytotoxic and non-immunogenic cross-linkable biomaterialYong Y Peng, Ayumi Yoshizumi, Stephen J Danon, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|July 27, 2021
The Mutant Mouse Resource and Research Center (MMRRC): the NIH-supported National Public Repository and Distribution Archive of Mutant Mouse Models in the USAJames Amos-Landgraf, Craig Franklin, Virginia Godfrey, et al.
Communications Chemistry|December 15, 2022
Active site remodelling of a cyclodipeptide synthase redefines substrate scopeEmmajay Sutherland, Christopher John Harding, Clarissa Melo Czekster
Scientific Reports|October 17, 2025
Viral oncogenes drive biphenotypic lymphoproliferative malignancy in transgenic miceDaniel A Rauch, John Harding, Ancy Joseph, et al.
Physical Chemistry Chemical Physics : PCCP|January 6, 2021
The importance of the bacterial cell wall in uranium(VI) biosorptionJoseph Hufton, John Harding, Thomas Smith, et al.
Journal of Atrial Fibrillation|December 14, 2016
Conjoined Inferior Pulmonary Veins during Pulmonary Vein Isolation: Prevalence and Novel Approach for Pulmonary Vein Isolation with CryoballoonJonathan Spagnola, Estelle Torbey, Rob Sangrigoli, et al.
Nature Chemical Biology|June 29, 2023
An anti-biofilm cyclic peptide targets a secreted aminopeptidase from P. aeruginosaChristopher John Harding, Marcus Bischoff, Megan Bergkessel, et al.
Blood|August 5, 2004
Enhanced tumorigenesis in HTLV-1 tax-transgenic mice deficient in interferon-gammaShibani Mitra-Kaushik, John Harding, Jay Hess, et al.
Pageof 7